Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

700-an-australasian-perspective-on-the-curative-treatment-of-patients-with-pancreatic-cancer-supportive-care-and-future-directions-for-management

Review: An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management

Wendy Muircroft

7 Dec 2016

https://doi.org/10.3332/ecancer.2016.700

Abstract | Full Article | PDF

684-next-generation-sequencing-in-nsclc-and-melanoma-patients-a-cost-and-budget-impact-analysis

Special Issue: Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten

28 Oct 2016

https://doi.org/10.3332/ecancer.2016.684

Abstract | Full Article | PDF

669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Richard Schilsky, Will Davies

24 Aug 2016

https://doi.org/10.3332/ecancer.2016.669

Abstract | Full Article | PDF

660-role-of-nanotechnology-and-gene-delivery-systems-in-trail-based-therapies

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

George E Naoum, Fady Tawadros, Ammad Ahmad Farooqi, Muhammad Zahid Qureshi, Sobia Tabassum, Waleed Arafat, Donald J Buchsbaum

1 Aug 2016

https://doi.org/10.3332/ecancer.2016.660

Abstract | Full Article | PDF

649-cancer-associated-thrombotic-microangiopathy

Review: Cancer-associated thrombotic microangiopathy

K Govind Babu, Gita R Bhat

28 Jun 2016

https://doi.org/10.3332/ecancer.2016.649

Abstract | Full Article | PDF

638-the-steady-progress-of-targeted-therapies-promising-advances-for-lung-cancer

Review: The steady progress of targeted therapies, promising advances for lung cancer

Lorenzo Bombardelli, Anton Berns

28 Apr 2016

https://doi.org/10.3332/ecancer.2016.638

Abstract | Full Article | PDF

632-characterisation-of-the-triple-negative-breast-cancer-phenotype-associated-with-the-development-of-central-nervous-system-metastases

Review: Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

Katerin Rojas Laimito, Angelo Gámez-Pozo, Juan Sepúlveda, Luis Manso, Rocío López-Vacas, Tomás Pascual, Juan A Fresno Vara, Eva Ciruelos

11 Apr 2016

https://doi.org/10.3332/ecancer.2016.632

Abstract | Full Article | PDF | Spanish

626-targeted-agents-in-epithelial-ovarian-cancer-review-on-emerging-therapies-and-future-developments

Review: Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments

Rajitha Lokadasan, Francis V James, Geetha Narayanan, Pranab K Prabhakaran

8 Mar 2016

https://doi.org/10.3332/ecancer.2016.626

Abstract | Full Article | PDF

582-effectiveness-and-safety-of-monoclonal-antibodies-for-metastatic-colorectal-cancer-treatment-systematic-review-and-meta-analysis

Review: Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis

Bruno Rosa, José Paulo de Jesus, Eduardo L de Mello, Daniel Cesar, Mauro M Correia

15 Oct 2015

https://doi.org/10.3332/ecancer.2015.582

Abstract | Full Article | PDF | Portuguese

564-highlights-from-the-2015-win-symposium-novel-targets-innovative-agents-and-advanced-technologies-a-winning-strategy

Conference Report: Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies—a WINning strategy?

Richard L Schilsky

13 Aug 2015

https://doi.org/10.3332/ecancer.2015.564

Abstract | Full Article | PDF

More from ecancer